0001615774-17-002698.txt : 20170525 0001615774-17-002698.hdr.sgml : 20170525 20170525161150 ACCESSION NUMBER: 0001615774-17-002698 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170525 DATE AS OF CHANGE: 20170525 EFFECTIVENESS DATE: 20170525 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Enumeral Biomedical Holdings, Inc. CENTRAL INDEX KEY: 0001561551 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 990376434 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-287510 FILM NUMBER: 17870087 BUSINESS ADDRESS: STREET 1: 200 CAMBRIDGEPARK DRIVE, SUITE 2000 CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: (617) 674-1865 MAIL ADDRESS: STREET 1: 200 CAMBRIDGEPARK DRIVE, SUITE 2000 CITY: CAMBRIDGE STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: CERULEAN GROUP, INC. DATE OF NAME CHANGE: 20121102 D 1 primary_doc.xml X0707 D LIVE 0001561551 Enumeral Biomedical Holdings, Inc. 200 CAMBRIDGEPARK DRIVE, SUITE 2000 CAMBRIDGE MA MASSACHUSETTS 02140 (617) 945-9146 DELAWARE Cerulean Group, Inc. CERULEAN GROUP, INC. Corporation true 2012 Wael Fayad 200 Cambridge Park Drive, Suite 2000 Cambridge MA MASSACHUSETTS 02140 Executive Officer Director Kevin G. Sarney 200 CAMBRIDGEPARK DRIVE, SUITE 2000 Cambridge MA MASSACHUSETTS 02140 Executive Officer Barry Buckland, Ph.D. 200 CAMBRIDGEPARK DRIVE, SUITE 2000 Cambridge MA MASSACHUSETTS 02140 Director Robert J. Easton 200 CAMBRIDGEPARK DRIVE, SUITE 2000 Cambridge MA MASSACHUSETTS 02140 Director Allan P. Rothstein 200 CAMBRIDGEPARK DRIVE, SUITE 2000 Cambridge MA MASSACHUSETTS 02140 Director Paul J. Sekhri 200 CAMBRIDGEPARK DRIVE, SUITE 2000 Cambridge MA MASSACHUSETTS 02140 Director Robert L. Van Nostrand 200 CAMBRIDGEPARK DRIVE, SUITE 2000 Cambridge MA MASSACHUSETTS 02140 Director Pharmaceuticals Decline to Disclose 06b false 2017-05-19 false true true true false 0 GP NURMENKARI INC. 153480 None None 64 WALL STREET, SUITE 402 NORWALK CT CONNECTICUT 06850 AL ALABAMA AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT DE DELAWARE DC DISTRICT OF COLUMBIA FL FLORIDA GA GEORGIA ID IDAHO IL ILLINOIS IN INDIANA IA IOWA KS KANSAS KY KENTUCKY LA LOUISIANA ME MAINE MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA MS MISSISSIPPI MO MISSOURI MT MONTANA NV NEVADA NH NEW HAMPSHIRE NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA OH OHIO OK OKLAHOMA OR OREGON PA PENNSYLVANIA RI RHODE ISLAND SC SOUTH CAROLINA TX TEXAS UT UTAH VT VERMONT VA VIRGINIA WA WASHINGTON WV WEST VIRGINIA WI WISCONSIN PR PUERTO RICO false Katalyst Securities LLC 112494 None None 630 THIRD AVENUE, 5TH FLOOR NEW YORK NY NEW YORK 10017 AL ALABAMA AK ALASKA AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT DE DELAWARE DC DISTRICT OF COLUMBIA FL FLORIDA GA GEORGIA ID IDAHO IL ILLINOIS IN INDIANA IA IOWA KS KANSAS KY KENTUCKY LA LOUISIANA ME MAINE MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA MS MISSISSIPPI MO MISSOURI NV NEVADA NH NEW HAMPSHIRE NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA ND NORTH DAKOTA OH OHIO OK OKLAHOMA OR OREGON PA PENNSYLVANIA RI RHODE ISLAND SC SOUTH CAROLINA TX TEXAS UT UTAH VT VERMONT VA VIRGINIA WA WASHINGTON WV WEST VIRGINIA WI WISCONSIN false 3600000 668000 2932000 Total offering amount includes additional $600,000 of securities that may be sold pursuant to oversubscriptions false 15 66800 0 Cash compensation equal to 10% of the gross proceeds of the offering. 0 false Enumeral Biomedical Holdings, Inc. /s/ Kevin G. Sarney Kevin G. Sarney Vice President of Finance 2017-05-25